Cardiac cachexia: A systematic overview
The DOI matches its Crossref record; 352 of the 352 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–352 of 352
Vogt, A., Qian, Y., McGuire, T. F., Hamilton, A. D., & Sebti, S. M. (1996) · PubMed · Cited by 164
Schwartz, M. W., & Morton, G. J. (2002) · Nature · doi:10.1038/418595a · Cited by 163
The Nutrition Implications of Cardiac Cachexia
Freeman, L. M., & Roubenoff, R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1994.tb01358.x · Cited by 163
Peptidomimetic Regulation of Growth Hormone Secretion
Smith, R. G. (1997) · Endocrine Reviews · doi:10.1210/er.18.5.621 · Cited by 160
A BRIEF HISTORY OF TESTOSTERONE
FREEMAN, E. R., BLOOM, D. A., & McGUIRE, E. J. (2001) · Journal of Urology · doi:10.1097/00005392-200102000-00004 · Cited by 156
von Haehling, S., Jankowska, E. A., Morgenthaler, N. G., Vassanelli, C., Zanolla, L., Rozentryt, P., Filippatos, G. S., Doehner, W., Koehler, F., Papassotiriou, J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.08.012 · Cited by 155
Self-citationMatsumori, A., Shioi, T., Yamada, T., Matsui, S., & Sasayama, S. (1994) · Circulation · doi:10.1161/01.cir.89.3.955 · Cited by 155
Molecular regulation of muscle cachexia: it may be more than the proteasome.
Hasselgren, P.-O., Wray, C., & Mammen, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5849 · Cited by 146
Medicinal Applications of Delta-9-Tetrahydrocannabinol and Marijuana
Voth, E. A., & Schwartz, R. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-10-199705150-00008 · Cited by 145
Sanders, P. M., Russell, S. T., & Tisdale, M. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602725 · Cited by 142
Mechanisms of skeletal muscle atrophy
Ventadour, S., & Attaix, D. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000245731.25383.de · Cited by 141
Therapeutic effects of ghrelin on endotoxic shock in rats
Chang, L., Zhao, J., Yang, J., Zhang, Z., Du, J., & Tang, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01972-1 · Cited by 141
Skudicky, D., Bergemann, A., Sliwa, K. S., Candy, G. P., & Sareli, P. (2001) · Circulation · doi:10.1161/01.cir.103.8.1083 · Cited by 138
Windmeier, C., & Gressner, A. M. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00314-x · Cited by 137
Khosla, S., & Melton, L. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070341 · Cited by 136
de Lorgeril, M., Salen, P., Accominotti, M., Cadau, M., Steghens, J., Boucher, F. R., & de Leiris, J. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00179-9 · Cited by 134
Tumour necrosis factor-? and the failing heart
von Haehling, S., Jankowska, E. A., & Anker, S. D. (2004) · Basic Research in Cardiology · doi:10.1007/s00395-003-0433-8 · Cited by 133
Self-citationZamir, O. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420020052008 · Cited by 133
Loss of bone mineral in patients with cachexia due to chronic heart failure
Anker, S. D., Clark, A. L., Teixeira, M. M., Hellewell, P. G., & Coats, A. J. S. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00927-8 · Cited by 132
Self-citationPilot trial of albuterol in spinal muscular atrophy
Kinali, M., Mercuri, E. M., Main, M. L., Biasia, F. D., Karatza, A., Higgins, R., Banks, L. M., Manzur, A. Y., & Muntoni, F. (2002) · Neurology · doi:10.1212/wnl.59.4.609 · Cited by 132
Davies, M. K., Gibbs, C. R., & Lip, G. Y. H. (2000) · PubMed Central · doi:10.1136/bmj.320.7230.297 · Cited by 132
Anker, S., Steinborn, W., & Strassburg, S. (2004) · Annals of Medicine · doi:10.1080/07853890410017467 · Cited by 129
Self-citationHyperleptinaemia in chronic heart failure Relationships with insulin
Leyva, F., Anker, S. D., Egerer, K., Stevenson, J. C., Kox, W. J., & Coats, A. J. S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1045 · Cited by 127
Self-citationClenbuterol, a β-Adrenoceptor Agonist, Increases Relative Muscle Strength in Orthopaedic Patients
Maltin, C. A., Delday, M. I., Watson, J. S., Heys, S. D., Nevison, I. M., Ritchie, I. K., & Gibson, P. H. (1993) · Clinical Science · doi:10.1042/cs0840651 · Cited by 126
Sakata, I., Yamazaki, M., Inoue, K., Hayashi, Y., Kangawa, K., & Sakai, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00294-5 · Cited by 125
Regulation of IκB kinase and NF-κB in contracting adult rat skeletal muscle
Ho, R. C., Hirshman, M. F., Li, Y., Cai, D., Farmer, J. R., Aschenbach, W. G., Witczak, C. A., Shoelson, S. E., & Goodyear, L. J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00632.2004 · Cited by 124
Krum, H., Ashton, E., Reid, C. M., Kalff, V., Rogers, J., Amarena, J., Singh, B., & Tonkin, A. M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.09.008 · Cited by 122
Koohmaraie, M., Shackelford, S. D., Muggli-Cockett, N. E., & STONE, R. T. (1991) · Journal of Animal Science · doi:10.2527/1991.69124823x · Cited by 122
Sliwa, K. S., Woodiwiss, A. J., Kone, V. N., Candy, G. P., Badenhorst, D., Norton, G. R., Zambakides, C. A., Peters, F., & Essop, R. (2004) · Circulation · doi:10.1161/01.cir.0000112568.48837.60 · Cited by 119
Ryall, J. G., Sillence, M. N., & Lynch, G. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706669 · Cited by 113
Simons, J. P., Aaronson, N. K., Vansteenkiste, J., ten Velde, G. P. M., Muller, M. J., Drenth, B. M. H., Erdkamp, F., Cobben, E. G., Schoon, E. J., Smeets, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1077 · Cited by 113
Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice
Xia, Q., Pang, W., Pan, H., Zheng, Y., Kang, J.-S., & Zhu, S. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.016 · Cited by 113
Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor-α
Wagner, D. R., Combes, A., McTiernan, C., Sanders, V. J., Lemster, B., & Feldman, A. M. (1998) · Circulation Research · doi:10.1161/01.res.82.1.47 · Cited by 113
Metabolic Actions of Growth Hormone in Man.
KYHO, K., O’Sullivan, A., & Hoffman, D. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.suppl_s57 · Cited by 111
Doehner, W., Pflaum, C. D., Rauchhaus, M., Godsland, I. F., Egerer, K., Cicoira, M., Florea, V., Sharma, R., Bolger, A. P., Coats, A. J. S., et al. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450727 · Cited by 111
Self-citationRothwell, N. J., Stock, M. J., & Sudera, D. K. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11211.x · Cited by 109
McCarthy, H. D., Crowder, R., Dryden, S. D., & Williams, G. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90229-1 · Cited by 105
Muscle wasting in cardiac cachexia
Strassburg, S., Springer, J., & Anker, S. D. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.03.013 · Cited by 103
Self-citationReiter, E. O. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50025-x · Cited by 103
Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells
Rubins, J. B., Greatens, T. M., Kratzke, R. A., Tan, A., Polunovsky, V. A., & Bitterman, P. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709020 · Cited by 102
Cloning and characterization of the 5′-flanking region of the human ghrelin gene
Kishimoto, M., Okimura, Y., Nakata, H., Kudo, T., Iguchi, G., Takahashi, Y., Kaji, H., & Chihara, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00722-8 · Cited by 101
Knox, J. J., Siu, L. L., Chen, E. X., Dimitroulakos, J., Kamel‐Reid, S., Moore, M. J., Chin, S. F., Irish, J., Laframboise, S., & Oza, A. M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.013 · Cited by 101
Reversal of COPD-associated weight loss using the anabolic agent oxandrolone
Yeh, S.-S., DeGuzman, B., & Kramer, T. (2002) · Chest · doi:10.1378/chest.122.2.421 · Cited by 101
Myostatin expression in ventricular myocardium in a rat model of volume‐overload heart failure
Shyu, K. G., Lu, M. J., Wang, B. W., Sun, H. Y., & Chang, H. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01718.x · Cited by 100
Amiodarone Inhibits Production of Tumor Necrosis Factor-α by Human Mononuclear Cells
Matsumori, A., Ono, K., Nishio, R., Nose, Y., & Sasayama, S. (1997) · Circulation · doi:10.1161/01.cir.96.5.1386 · Cited by 99
Cytokine-binding proteins: stimulating antagonists
Klein, B., & Brailly, H. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80161-8 · Cited by 99
Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis
Krysiak, R. G., Obuchowicz, E., & Herman, Z. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400130 · Cited by 98
The cancer anorexia-cachexia syndrome.
Nelson, K. A. (2000) · PubMed · Cited by 98
Matsumori, A., Ono, K., Nishio, R., Igata, H., Pharm, B., Shioi, T., Matsui, S., Furukawa, Y., Iwasaki, A., Nose, Y., et al. (1997) · Circulation · doi:10.1161/01.cir.96.5.1501 · Cited by 96
Cachexia: a therapeutic approach beyond cytokine antagonism
von Haehling, S., Genth‐Zotz, S., Anker, S. D., & Volk, H. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00245-0 · Cited by 94
Self-citationEpidemiology of weight loss in humans with special reference to wasting in the elderly
Wallace, J. I., & Schwartz, R. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00246-2 · Cited by 93
Bolger, A. P., & Anker, S. D. (2000) · Drugs · doi:10.2165/00003495-200060060-00002 · Cited by 93
Self-citationCostelli, P., Bossola, M., Muscaritoli, M., Grieco, G., Bonelli, G., Bellantone, R., Doglietto, G., Baccino, F., & Fanelli, F. (2002) · Cytokine · doi:10.1006/cyto.2002.1036 · Cited by 93
Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects
Leeuwen, S. D. Z.-V., van den Berg, J. W. O., Wattimena, J. L. D., van der Gaast, A., Swart, G. R., Wilson, J. H. P., & Dagnelie, P. C. (2000) · Metabolism · doi:10.1053/meta.2000.6740 · Cited by 92
Williams, G. H., Cai, X., Elliott, J. C., & Harrold, J. A. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.005 · Cited by 92
Recent Insights into the Role of Tumor Necrosis Factor in the Failing Heart
Mann, D. L. (2001) · Heart Failure Reviews · doi:10.1023/a:1011449708842 · Cited by 92
Lainščak, M., Keber, I., & Anker, S. D. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.061 · Cited by 91
Self-citationLainščak, M., Cleland, J. G. F., Lenzen, M. J., Nabb, S., Keber, I., Folláth, F., Michel Komajda, N., & Swedberg, K. B. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.08.001 · Cited by 88
Effect of Thalidomide on Cardiac Remodeling in Chronic Heart Failure
Gullestad, L. L., Ueland, T., Fjeld, J. G., Holt, E., GUNDERSEN, T., BREIVIK, K., Følling, M., Hodt, A., Skårdal, R., KJEKSHUS, J. K., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.564971 · Cited by 87
A Review of Homocysteine and Heart Failure
Herrmann, M., Taban‐Shomal, O., Hübner, U., Böhm, M., & Herrmann, W. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.11.016 · Cited by 85
Growth hormone resistance in chronic heart failure and its therapeutic implications
Cicoira, M., Kalra, P. R., & Anker, S. D. (2003) · Journal of Cardiac Failure · doi:10.1054/jcaf.2003.23 · Cited by 84
Self-citationGenth‐Zotz, S., von Haehling, S., Bolger, A. P., Kalra, P. R., Wensel, R., Coats, A. J. S., & Anker, S. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02839-4 · Cited by 83
Self-citationBranched-chain amino acids: the best compromise to achieve anabolism?
Laviano, A., Muscaritoli, M., Cascino, A., Preziosa, I., Inui, A., Mantovani, G., & Fanelli, F. R. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000172581.79266.19 · Cited by 82
Recent Insights into the Role of Tumor Necrosis Factor in the Failing Heart
Mann, D. L. (2001) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-1449-7_2 · Cited by 80
Changes in skeletal muscle gene expression following clenbuterol administration
Spurlock, D. M., McDaneld, T. G., & McIntyre, L. M. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-320 · Cited by 80
Cardiac cachexia in early literature: a review of research prior to Medline
Doehner, W., & Anker, S. D. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00230-9 · Cited by 79
Self-citationDoehner, W., Rauchhaus, M., Godsland, I. F., Egerer, K., Niebauer, J., Sharma, R., Cicoira, M., Florea, V. G., Coats, A. J. S., & Anker, S. D. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00022-0 · Cited by 78
Self-citationFat loss in cachexia—is there a role for adipocyte lipolysis?
Rydén, M., & Arner, P. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.09.009 · Cited by 78
Combaret, L., Rallière, C., Taillandier, D., Tanaka, K., & Attaix, D. (1999) · Molecular Biology Reports · doi:10.1023/a:1006955832323 · Cited by 77
Metabolic and nutritional disorders in cardiac cachexia
Mustafa, I., & Leverve, X. M. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00627-x · Cited by 77
Harcourt, L. J., Schertzer, J. D., Ryall, J. G., & Lynch, G. S. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.08.012 · Cited by 77
Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
Weber, K. T., Andrews, V., Janicki, J. S., Likoff, M. J., & Reichek, N. (1982) · Circulation · doi:10.1161/01.cir.66.6.1262 · Cited by 77
Statins and the Role of Nitric Oxide in Chronic Heart Failure
von Haehling, S., Anker, S. D., & Bassenge, E. (2003) · Heart Failure Reviews · doi:10.1023/a:1022103222857 · Cited by 76
Self-citationThe need for a standardized definition for cachexia in chronic illness
Springer, J., von Haehling, S., & Anker, S. D. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0247 · Cited by 76
Self-citationRyall, J. G., Gregorevic, P., Plant, D. R., Sillence, M. N., & Lynch, G. S. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00324.2002 · Cited by 76
Drott, C., Persson, H., & Lundholm, K. (1989) · Clinical Physiology · doi:10.1111/j.1475-097x.1989.tb00997.x · Cited by 74
Prognosis and therapy approaches of cardiac cachexia
Springer, J., Filippatos, G. S., Akashi, Y. J., & Anker, S. D. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221585.94490.09 · Cited by 74
Self-citationA NOVEL SELECTIVE EXTRACORPOREAL INTERVENTION IN SEPSIS
Schefold, J. C., von Haehling, S., Corsepius, M., Pohle, C., Kruschke, P., Zuckermann, H., Volk, H., & Reinke, P. (2007) · Shock · doi:10.1097/shk.0b013e31804f5921 · Cited by 74
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies
Holstein, S. A., Knapp, H. R., Clamon, G. H., Murry, D. J., & Hohl, R. J. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0013-8 · Cited by 74
Brown‐Séquard revisited: a lesson from history on the placebo effect of androgen treatment
Cussons, A. J., Walsh, J. P., Bhagat, C. I., & Fletcher, S. J. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb05014.x · Cited by 71
Hryniewicz, K. M., Androne, A. S., Hudaihed, A., & Katz, S. D. (2003) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(03)00582-7 · Cited by 70
Plasma leptin concentrations and energy expenditure in heart failure patients
Toth, M. J., Gottlieb, S. S., Fisher, M. L., Ryan, A. S., Nicklas, B. J., & Poehlman, É. T. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90065-2 · Cited by 69
Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients.
Llovera, M., García-Martínez, C., Agell, N., López-Soriano, F., Authier, F., Ghérardi, R., & Argilés, J. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2.1.69 · Cited by 68
Pilot trial of albuterol in Duchenne and Becker muscular dystrophy
Fowler, E., Graves, M. C., Wetzel, G. T., & Spencer, M. J. (2004) · Neurology · doi:10.1212/01.wnl.0000118530.71646.0f · Cited by 66
Solheim, S., Seljeflot, I., Arnesen, H., Eritsland, J., & Eikvar, L. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00725-5 · Cited by 66
Growth Hormone in the Treatment of Dilated Cardiomyopathy
Frustaci, A., Gentiloni, N., & Russo, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350915 · Cited by 66
Garcia‐Martínez, C., Llovera, M., Agell, N., López-Soriano, F. J., & Argilés, J. M. A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2848 · Cited by 64
Cachexia: Common, Deadly, With an Urgent Need for Precise Definition and New Therapies
Lainščak, M., Filippatos, G. S., Gheorghiade, M., Fonarow, G. C., & Anker, S. D. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.065 · Cited by 64
Self-citationColl, A. P. (2007) · Clinical Science · doi:10.1042/cs20070105 · Cited by 63
Mettauer, B., Rouleau, J. L., & Burgess, J. H. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90648-9 · Cited by 63
Moore, N., Pegg, G. G., & Sillence, M. N. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.3.e475 · Cited by 61
Nutritional abnormalities contributing to cachexia in chronic illness
Witte, K. K., & Clark, A. L. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00231-0 · Cited by 61
Westman, G., Bergman, B., Albertsson, M., Kadar, L., Gustavsson, G., Thaning, L., Andersson, M. V., Straumits, A., Jeppsson, B. W., Lindén, C. J., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00398-0 · Cited by 61
The Two Faces of NF?B in Cell Survival Responses
Graham, B. A., & Gibson, S. B. (2005) · Cell Cycle · doi:10.4161/cc.4.10.2047 · Cited by 57
Dietary Intake of Various Nutrients in Older Patients with Congestive Heart Failure
Gorelik, O., Almoznino-Sarafian, D., Feder, I., Wachsman, O., Alon, I., Litvinjuk, V., Roshovsky, M., Modai, D., & Cohen, N. (2003) · Cardiology · doi:10.1159/000071246 · Cited by 55
George, I., Xydas, S., MANCINI, D. M., LaManca, J. J., Tullio, M. R. D., Marboe, C. C., Shane, E. J., Schulman, A. R., Colley, P. M., Petrilli, C. M., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.017 · Cited by 54
Branched-chain amino acid supplementation during bed rest: effect on recovery
Stein, T. P., Donaldson, M. R., Leskiw, M. J., Schluter, M. D., Baggett, D. W., & Boden, G. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00481.2002 · Cited by 53
The cardiac component of cardiac cachexia
Florea, V. G., Henein, M. Y., Rauchhaus, M., Koloczek, V., Sharma, R., Doehner, W., Poole-Wilson, P. A., Coats, A. J. S., & Anker, S. D. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123314 · Cited by 53
Self-citationFlorea, V. G., Moon, J., Pennell, D. J., Doehner, W., Coats, A. J. S., & Anker, S. D. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.05.050 · Cited by 52
Self-citationFranz, I. W., Tönnesmann, U., & Müller, J. W. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00024-7 · Cited by 52
McMillan, D. C., Preston, T., Watson, W. S., Simpson, J. M., Fearon, K. C. H., Shenkin, A., Burns, H. J. G., & McArdle, C. S. (1994) · British journal of surgery · doi:10.1002/bjs.1800810727 · Cited by 50
Effect of thalidomide in patients with chronic heart failure
Gullestad, L. L., Semb, A. G., Holt, E., Skårdal, R., Ueland, T., Yndestad, A., Frøland, S. S., & Aukrust, P. (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)80019-9 · Cited by 50
RAJAGOPALAN, R., Rosenson, R. S., FERNANDES, A., Khan, M. A., & MURRAY, F. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.09.016 · Cited by 48
Nutrition and cardiac cachexia
Azhar, G., & Wei, J. Y. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000198060.10991.50 · Cited by 48
Sharma, R. K., von Haehling, S., Rauchhaus, M., Bolger, A. P., Genth‐Zotz, S., Doehner, W., Oliver, B. G. G., Poole-Wilson, P. A., Volk, H., Coats, A. J. S., et al. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.09.013 · Cited by 47
Self-citationGaucher, E. A., Miyamoto, M. M., & Benner, S. A. (2003) · Genetics · doi:10.1093/genetics/163.4.1549 · Cited by 47
Kovačić, D., Marinsek, M., Gobec, L., Lainščak, M., & Podbregar, M. (2007) · Clinical Research in Cardiology · doi:10.1007/s00392-007-0571-3 · Cited by 45
Daily energy requirements in heart failure patients
Toth, M. J., Gottlieb, S. S., Fisher, M. L., & Poehlaman, E. T. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90233-x · Cited by 45
Endothelial function and its assessment
Felmeden, D. C., & Lip, G. Y. H. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1319 · Cited by 44
Bahrmann, P., Hengst, U., Richartz, B. M., & Figulla, H. R. (2003) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.09.005 · Cited by 43
Zamir, O., Hasselgren, P.-O. J., von Allmen, D., & Fischer, J. E. (1993) · Metabolism · doi:10.1016/0026-0495(93)90036-n · Cited by 39
Thalidomide revisited: pharmacology and clinical applications
Calabrese, L. H., & Resztak, K. E. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.12.2043 · Cited by 38
Acute negative inotropic effects of homocysteine are mediated via the endothelium
Kennedy, R. H., Owings, R. A., Shekhawat, N. S., & Joseph, J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01042.2003 · Cited by 37
Effects of Neuropeptide Y on Appetite
Kokot, F., & Ficek, R. (1999) · Mineral and Electrolyte Metabolism · doi:10.1159/000057464 · Cited by 36
Burniston, J. G., McLean, L., Beynon, R. J., & Goldspink, D. F. (2006) · Muscle & Nerve · doi:10.1002/mus.20684 · Cited by 35
Future prospects of anticytokine therapy in chronic heart failure
von Haehling, S., & Anker, S. D. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.163 · Cited by 34
Self-citationJatoi, A., Alberts, S. R., Foster, N. R., Morton, R. F., Burch, P. A., Block, M., Nguyen, P. L., & Kugler, J. W. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0787-6 · Cited by 33
New therapies for heart failure: is thalidomide the answer?
Davey, P. P., & Ashrafian, H. (2000) · QJM · doi:10.1093/qjmed/93.5.305 · Cited by 33
Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in experimental models
Tirapegui, J. (1999) · International Journal of Food Sciences and Nutrition · doi:10.1080/096374899101102 · Cited by 32
Agoston, I., Dibbs, Z. I., Wang, F., Muller, G. W., Zeldis, J. B., Mann, D. L., & Bozkurt, B. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.128684 · Cited by 32
Uc, E. Y., Lambert, C. P., Harik, S. I., Rodnitzky, R. L., & Evans, W. J. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200307000-00011 · Cited by 31
Thalidomide and immunomodulatory drugs in the treatment of cancer
Bamias, A., & Dimopoulos, M. A. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.1.45 · Cited by 31
Effects of pentoxifylline in endotoxinemia in human volunteers.
Zabel, P., Schönharting, M., Schade, U. F., & Schlaak, M. S. (1991) · PubMed · Cited by 30
Cellular Endotoxin Desensitization in Patients with Severe Chronic Heart Failure
Sharma, R. K., Bolger, A. P., Rauchhaus, M., von Haehling, S., Doehner, W., Adcock, I. M., Barnes, P. J., Poole-Wilson, P. A., Volk, H., Coats, A. J. S., et al. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.09.014 · Cited by 29
Self-citationCosta, A. M., Spence, K. T., Plata‐Saláman, C. R., & ffrench-Mullen, J. M. H. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020880 · Cited by 29
The Regulation of Feeding: A Cross Talk between Peripheral and Central Signalling
Brunetti, L., Nisio, C. D., Orlando, G., Ferrante, C., & Vacca, M. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800203 · Cited by 29
Tomoda, H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00796-6 · Cited by 28
Agents targeting inflammation in heart failure
Gullestad, L. L., KJEKSHUS, J. K., Damås, J. K., Ueland, T., Yndestad, A., & Aukrust, P. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.557 · Cited by 27
Genth‐Zotz, S., von Haehling, S., Bolger, A. P., Kalra, P. R., Wensel, R., Coats, A. J. S., Volk, H., & Anker, S. D. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.010 · Cited by 26
Self-citationPlasma amino acid levels in patients with chronic obstructive pulmonary disease.
Schols, A. M. W. J., Deutz, N. E. P., Mostert, R., & Wouters, E. F. �. (1993) · PubMed · Cited by 26
Melanocortin interventions in cachexia: how soon from bench to bedside?
DeBoer, M. D. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328108f441 · Cited by 24
Nutritional Recommendations for Patients With Heart Failure
Lennie, T. A. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200607000-00005 · Cited by 24
Novel treatments for cancer cachexia
Bossola, M., Pacelli, F., & Doglietto, G. B. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.8.1241 · Cited by 24
Jankowska, E. A., von Haehling, S., Czarny, A., Zaczyńska, E., Kuś, A., Anker, S. D., Banasiak, W., & Ponikowski, P. P. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.05.013 · Cited by 24
Self-citationvon Haehling, S., Genth‐Zotz, S., Bolger, A. P., Kalra, P. R., Kemp, M., Adcock, I. M., Poole-Wilson, P. A., Dietz, R., & Anker, S. D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.022 · Cited by 24
Self-citationCardiac implications for the use of β 2 ‐adrenoceptor agonists for the management of muscle wasting
Molenaar, P., Chen, L., & Parsonage, W. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706670 · Cited by 24
Lisinopril administration improves insulin action in aged patients with hypertension.
Paolisso, G., Balbi, V., Gambardella, A., Varricchio, G., Tortoriello, R., Saccomanno, F., Amato, L., & Varricchio, M. (1995) · PubMed · Cited by 21
Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure
Feng, Q., LAMBERT, M., Callow, I. D., & ARNOLD, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104610 · Cited by 20
Effect of salbutamol on innervated and denervated rat soleus muscle
Šoic-Vranic, T., Bobinac, D., Bajek, S., Jerkovic, R., Malnar-Dragojevic, D., & Nikolic, M. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005001200008 · Cited by 19
The Major Components of Human Energy Balance During Chronic ??-Adrenergic Blockade
Lamont, L. S., Brown, T., Riebe, D. A., & Caldwell, M. J. (2000) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200007000-00006 · Cited by 18
Plasma amino acid levels in patients with chronic obstructive pulmonary disease
Schols, A. M. W. J., Deutz, N. E. P., Mostert, R., & Wouters, E. F. �. (1992) · Clinical Nutrition · doi:10.1016/0261-5614(92)90265-r · Cited by 18
Macfarlane, D. P., & Fisher, M. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606050-00002 · Cited by 18
The effects of beta agonists on muscle cells in culture
Harper, J. M. M., Mackinson, I., & BUTTERY, P. J. (1990) · Domestic Animal Endocrinology · doi:10.1016/0739-7240(90)90005-k · Cited by 17
Ullman, B., Pernow, J., Lundberg, J. M., Åström, H., & Bergfeldt, L. (2002) · Clinical Science · doi:10.1042/cs1030535 · Cited by 17
Serum leptin concentration in heart failure patients: does the literature reflect reality?
Filippatos, G. S., Tsilias, K., Baltopoulos, G., & Anthopoulos, L. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1930 · Cited by 16
Toll-like receptor modulation in cardiovascular disease: a target for intervention?
Földes, G., von Haehling, S., & Anker, S. D. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.857 · Cited by 14
Self-citationMuscle and serum changes with salbutamol administration in aerobically exercised rats
Cepero, M., Pérez‐Pertejo, Y., Cubrı́a, J. C., Reguera, R. M., Balaña‐Fouce, R., Ordóñez, C., & Escudero, D. O. (2000) · Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology · doi:10.1016/s0742-8413(00)00094-3 · Cited by 14
Hypothesis: Myostatin is a mediator of cardiac cachexia
Hoenig, M. R. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.07.058 · Cited by 13
Investigational agents for treatment of AIDS-related Kaposi’s sarcoma
Konstantinopoulos, P. A., Sullivan, R. J., Karamouzis, M. V., & Dezube, B. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.495 · Cited by 11
Investigational treatments for multiple myeloma
Bringhen, S., Avonto, I., Magarotto, V., Boccadoro, M., & Palumbo, A. P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.12.1565 · Cited by 10
Statins for heart failure: still caught in no man's land?
von Haehling, S. (2008) · Clinical Science · doi:10.1042/cs20080530 · Cited by 8
The significance of Leptin in human — do we know it yet?
Doehner, W., & Anker, S. D. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00396-x · Cited by 7
Self-citation
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citation2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citation2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Self-citation
Metadata
- Authors
- von Haehling, S., Lainscak, M., Springer, J., & Anker, S. D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 121
- Issue
- 3
- Pages
- 227-252
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1964925711
- Cited by
- 348
- References
- 352
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.